RNA, it hydrolyzes ATP and undergoes a conformation change to move the repressor domain and expose the CARDs for signaling, thus allowing stable interaction with ZAPS. ZAPS may also stabilize the binding of RNA to RIG-I, possibly by interacting with the RNA itself, or it may serve to stabilize the 'signaling-on' conformation of the repressor domain. The RIG-I signaling complex may then engage TRIM25 as well as other RIG-I signaling partners, leading to the binding of IPS-1 at its mitochondria-associated location and induction of downstream signaling to drive the innate immune response and limit virus infection. This model suggests that the effects of ZAPS on RIG-I signaling are under tight control to limit immune toxicity and autoimmunity that might develop as a result of constitutive RIG-I action. Future studies of ZAPS function should address how the innate immune-enhancing activity of ZAPS is regulated during viral infection.
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modifications of RIG-I, including covalent linkage to ISG (interferon-stimulated gene) proteins, phosphorylation and ubiquitination, which affect its signaling activity 1, [8] [9] [10] . For example, Lys63-linked polyubiquitination of RIG-I by the E3 ubiquitin ligase TRIM25 is critical for RIG-I activation and signaling 1 . TRIM25 interacts with RIG-I and delivers polyubiquitin to the CARDs to enhance its signaling 1 . Conversely, RIG-I can be deubiquinated by the ubiquitin carboxyl-terminal hydrolase CYLD, leading to inactivation of RIG-I-IPS-1 signaling 8 . It is important to assess the role of ZAPS in these processes. Does ZAPS affect TRIM25-mediated activation of RIG-I, and how are these interactions coordinated?
With the present study, Hayakawa et al. provide novel insights into the mechanisms of RIG-I signaling activation during virus infection (Fig. 1) . In resting cells, RIG-I is held in a closed conformation through its repressor domain. When RIG-I binds viral RIG-I signaling and shows a specific role for this PARP in antiviral responses, several issues about the mechanisms of ZAPS regulation of RIG-I have yet to be addressed. The binding of ZAPS to RIG-I seems to be dependent on RNA. RIG-I is proposed to engage its RNA ligand before interacting with ZAPS. It is still unclear whether ZAPS is required to participate in RNA binding to promote the oligomerization and activation of RIG-I. If that is the case, does ZAPS bind to specific ZAP-responsive element motifs in the RNA ligand to mediate its actions, and what role, if any, does p72 have in these interactions? Additionally, it remains unclear what role ZAP might have in RIG-I regulation and if ZAPS might interact with other RIG-I cofactors. Clarification of these aspects would be needed to delineate the complexity of the interaction between ZAPS and RIG-I and how it controls RIG-I signaling.
Beyond ZAPS, several accessory proteins that facilitate RIG-I activation have been described, and there is a growing list of post-translational p65), the transactivating subunit of the NF-κB complex 2 . This event represses chromatin in the region of several NF-κB-dependent genes and ensures that they are not transcribed unless cells are activated by the appropriate stimuli that trigger phosphorylation of Ser311 by the atypical protein kinase PKC-ζ 2 . These are very important observations, because they demonstrate a new layer of complexity in the regulation of NF-κB transcriptional activity transcription factor by the IKK complex involves its cytosolic-to-nuclear translocation mediated by the phosphorylation and subsequent proteasomal degradation of the inhibitory molecule IκBα 1 . However, in this issue of Nature Immunology, Levy and co-workers describe a previously unknown mechanism in which basal and activated NF-κB is controlled through the methyltransferase SETD6-mediated methylation of Lys310 of RelA (also indicates that demethylation of this residue is a prerequisite for the expression of NF-κB target genes under activating conditions. The pathophysiological relevance of these findings is confirmed by experiments in which a lower abundance of SETD6 in transformed cells enhances their tumorigenic potential in vitro and in vivo 2 , consistent with a role for NF-κB in cancer 7 . Furthermore, Levy et al. show that blood mononuclear cells from patients with rheumatoid arthritis or juvenile idiopathic arthritis have much lower expression of SETD6 mRNA, which suggests the importance of this newly identified pathway in human inflammatory disease 2 .
Once these authors establish the functional relevance of this previously unknown covalent modification of RelA, they go on to determine the precise mechanism whereby RelA methylated at Lys310 controls transcription 2 . They again do an unbiased screen, this time looking for protein motifs that could potentially interact with RelA methylated at Lys310. They find a positive 'hit' in the ankyrin-repeat domain of GLP, which selectively interacts with this modified RelA with an affinity similar to that of the positive control, histone H3 methylated at Lys9 (ref. 2) . Interestingly, GLP, along with its partner G9a, are known to methylate histone H3 at Lys9 in chromatin regions with repressed transcription 8 . Consistent with a role for this event in NF-κB function, chromatin-immunoprecipitation assays show that GLP and methylated histone H3 are lower in abundance at the promoters of canonical κB-responsive genes after stimulation with TNF and that knockdown of SETD6 results in less interaction of GLP with RelA 2 . Collectively, all these results suggest a model whereby activation of the NF-κB signaling cascade leads to the release of GLP, which results in the opening of chromatin, allowing efficient activation of κB-dependent gene transcription.
The next big issue that remains to be addressed is identification of the precise signal that triggers the whole process. Here, PKC-ζ enters the picture; PKC-ζ, along with PKC-λ and PKC-ι, forms the atypical PKC subfamily. In contrast to the classical and novel PKC isoforms, proteins of the atypical PKC subfamily are insensitive to lipids and Ca 2+ but interact with protein regulators and adaptors through a newly described PB1 proteinprotein interaction domain 9 . Levy et al. reason that the close proximity of Ser311, a target site for PKC-ζ phosphorylation in response to TNF 5 , to Lys310 might mean that methylation of RelA could be influenced by the PKC-ζ-mediated phosphorylation of Ser311 (ref. 2). Interestingly, through biochemical and cellular studies of PKC-ζ-deficient cells, they find the inactive p50-p50 homodimers in the κB-regulatory elements 3 . However, phosphorylation of RelA at Ser276 is not sufficient to promote binding of CBP, as Ser311 also needs to be phosphorylated in response to tumor necrosis factor (TNF) 5 . This serine residue is specifically targeted by PKC-ζ, which has been shown through genetic manipulations to be required for full NF-κB transcriptional activity in vivo and in cell culture 6 (Fig. 1) . Interestingly, Ser276 and Ser311 both reside in the Rel-homology-dimerization domain. Ser311 is in close proximity to Lys310, and it is unclear whether phosphorylation of Ser311 by PKC-ζ modulates the acetylation of Lys310. Nonetheless, Levy et al. show here that it affects Lys310 methylation, which has an effect on the transcriptional activity of many NF-κB target genes 2 . Their study stems from an unbiased screening of human protein lysine methyltransferases, in which they discover that one of these, SETD6, monomethylates chromatin-associated RelA at Lys310. A series of elegant biochemical experiments shows that methylated RelA resides in a histone H3-rich region near the promoters of several NF-κB target genes. This finding is important because it suggests that methylated RelA might have a repressive role in the control of gene expression under basal conditions. Indeed, knockdown of SETD6 gives rise to more κB-dependent transcription under basal conditions and, notably, under stimulated conditions as well. Thus, TNF activation correlates with lower abundance of methylated Lys310, which through chromatin remodeling and establish PKC-ζ as a critical mediator of the chromatin changes necessary for effective transcription of κB-dependent genes (Fig. 1) .
It is not surprising that the nuclear actions of NF-κB, a critical transcriptional regulator that controls the expression of thousands of genes, can be modulated and fine-tuned by mechanisms in addition to its all-or-nothing nuclear translocation. It is also known that even in the absence of stimuli, there are NF-κB subunits in the nucleus that are bound to gene-regulatory elements in the chromatin and that must be kept in check to prevent undesired, uncontrolled activity. Indeed, pioneering experiments established that dimers of the NF-κB subunit p50 associated with histone deacetylase sit on κB elements, which serves to deacetylate histones, therefore leading to closed, repressive chromatin that prevents gene expression under basal conditions 3 . After degradation of IκBα, p50-RelA heterodimers are released from the inhibitory complex and RelA is phosphorylated at Ser276 by protein kinase A and/or mitogen-and stress-activated protein kinase, promoting interaction of RelA with the transcriptional coactivator CBP 3 . This interaction results in more CBP-mediated acetylation of Lys310, which is apparently also important for transcriptional activation 4 and for the acetylation of histones by CBP; this results in the generation of an open, permissive chromatin structure, leading to full transcriptional activity of the NF-κB complex, which replaces patients with cancer to determine whether there are alterations in gene expression and/ or mutations in the genes encoding SETD6 or GLP and whether there are changes in the acetylation or methylation of Lys310 and/or phosphorylation of Ser311. All these analyses would help establish the pathway identified here as a potential new source of therapeutic targets in the treatment of cancer and inflammatory diseases.
at least one histone demethylase is promoted, and another in which RelA itself is methylated, thus recruiting GLP, which is antagonized by TNF-activated PKC-ζ.
Like every breakthrough, these new findings solve many mysteries but also raise several questions. For example, what is the subunit composition of the NF-κB complex that contains methylated RelA at the chromatin? Is there a methylated RelA-RelA homodimer or is it in fact a p50-RelA heterodimer? Is this mechanism applicable to all κB-dependent genes or just those with a more closed promoter conformation? Published results suggest that PKC-ζ directly phosphorylates IKKβ in vitro 11 and that PKC-ζ is required for activation of IKKβ in vivo 6 . It will be important to define the cell types in which PKC-ζ acts upstream of IKKβ and those in which it controls RelA transcriptional activity in vivo. Knock-in mouse lines expressing loss-of-function mutations of the sequence encoding Lys310 and Ser311 would help identify the physiological relevance of these modifications, as well as their importance in various diseases to which NF-κB has been linked. In this context, it will be of great interest to analyze samples from human that phosphorylation of Ser311 by PKC-ζ in response to TNF stimulation does in fact lead to displacement of GLP from RelA and therefore to more transcription of κB-dependent genes. Consistent with published results 6 , Levy et al. find that PKC-ζ-deficient cells have lower production of inflammatory cytokines 2 . Therefore, phosphorylation of RelA at Ser311 by PKC-ζ, in addition to favoring histone acetylation by allowing the recruitment of CBP, also inhibits histone methylation by preventing the interaction of GLP with RelA. This finding highlights the importance of the 'hot spot' at positions 310-311 and the relevance of PKC-ζ in its control (Fig. 1) . Interestingly, the regulation of histone methylation by NF-κB has been shown before to also occur as a consequence of activation of this transcription factor. Studies have shown that JMJD3, which demethylates histone H3 at Lys27, is expressed in macrophages activated by lipopolysaccharide 10 . It is believed that this enzyme, by erasing a critical histone mark, controls macrophage differentiation during chronic inflammation 10 . Therefore, a model emerges whereby histone-methylation interaction in NF-κB signaling takes place by two mechanisms: one in which the synthesis of Maruyama et al. now show that another TGF-β-dependent molecular mechanism is involved in Foxp3 expression. They examine the development of CD4 + Foxp3 + T reg cells and show that Foxp3 expression is regulated by cooperation of E2A, Id3 and GATA-3. Not only is Foxp3-dependent T reg cell development impaired in Id3 -/-mice but also their development of T H 17 cells is greater. As Foxp3 inhibits RORγt function 2 , T H 17 cells may be more abundant in these mice as a consequence of the downmodulation of Foxp3 expression. Surprisingly, Rorc expression is also regulated by E2A. Together these results indicate that T H 17 development is regulated by a balance the transcription factor GATA-3 act together in the regulation of Foxp3 expression 1 .
T reg cells suppress excessive immune responses and contribute to the prevention of autoimmune disease caused by potentially hazardous self-reactive T cells. Studies have also shown greater activity of T reg cells associated with tumors. Many laboratories have concentrated on identifying the molecular features of Foxp3 expression. An emerging picture is that Foxp3 expression is controlled by four defined regulatory regions, and indeed the binding of many transcription factors in these regions has already been identified (Fig. 1) . Notably, the activity of most of the transcription factors identified at present is induced by signaling through either the TCR or cytokine receptors, including the receptor for TGF-β. These transcription factors have cooperative activities that are able to induce and maintain Foxp3 expression. In addition, transcription factors The molecular mechanisms that control T reg and T H 17 development and the precise role of transforming growth factor-b in this process are complex and imperfectly understood. New findings indicate that the helix-loop-helix proteins E2A and Id3 are also critically involved in some of these processes.
